REPORT DESCRIPTION
Wound Care Biologics Market – Overview
Wound care biologics are bioengineered products used for non-healing wounds of the lower extremity.
Demand for wound care biologic products is expected to increase significantly as early intervention of
diabetic ulcer can prevent severe complications such as infection, hospitalization, and amputation. Wound
care biologics market is expected to gain significant traction, as the commercially available skin substitutes
have clinical and experimental evidence of efficacy in wound healing.
The wound care biologics market is expected to gain significant traction, with rise in global prevalence of
diabetes, as diabetic patients are prone to developing diabetic ulcers. According to the Global Diabetes
Community, 2017, an estimated 422 million adults are living with diabetes globally, and this is expected to
increase to 642 million by 2040.